Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) is 4.79% higher on its value in year-to-date trading and has touched a low of $377.85 and a high of $519.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VRTX stock was last observed hovering at around $416.96 in the last trading session, with the day’s gains setting it 5.04%.
Currently trading at $422.00, the stock is 2.80% and -5.69% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.77 million and changing 1.21% at the moment leaves the stock -7.72% off its SMA200. VRTX registered -2.71% loss for a year compared to 6-month loss of -13.55%. The firm has a 50-day simple moving average (SMA 50) of $447.461 and a 200-day simple moving average (SMA200) of $457.29025.
The stock witnessed a -9.85% gain in the last 1 month and extending the period to 3 months gives it a -13.39%, and is 3.04% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.67% over the week and 2.58% over the month.
Vertex Pharmaceuticals, Inc (VRTX) has around 5400 employees, a market worth around $108.68B and $10.62B in sales. Fwd P/E is 22.84. Profit margin for the company is -4.52%. Distance from 52-week low is 11.68% and -18.83% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.77%).
with sales reaching $2.79B over the same period.The EPS is expected to shrink by -96.83% this year, but quarterly earnings will post 10.26% year-over-year. Quarterly sales are estimated to grow 10.62% in year-over-year returns.
Vertex Pharmaceuticals, Inc (VRTX) Top Institutional Holders
2183.0 institutions hold shares in Vertex Pharmaceuticals, Inc (VRTX), with institutional investors hold 96.20% of the company’s shares. The shares outstanding are 257.74M, and float is at 256.90M with Short Float at 1.54%. Institutions hold 96.12% of the Float.
The top institutional shareholder in the company is CAPITAL WORLD INVESTORS with over 26.71 million shares valued at $12.52 billion. The investor’s holdings represent 10.3439% of the VRTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 22.98 million shares valued at $10.77 billion to account for 8.8983 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 21.31 million shares representing 8.2542% and valued at over $9.99 billion, while STATE STREET CORP holds 4.5415 of the shares totaling 11.73 million with a market value of $5.5 billion.
Vertex Pharmaceuticals, Inc (VRTX) Insider Activity
The most recent transaction is an insider sale by ALTSHULER DAVID, the company’s EVP, Chief Scientific Officer. SEC filings show that ALTSHULER DAVID sold 15 shares of the company’s common stock on Nov 15 ’24 at a price of $478.56 per share for a total of $7178.0. Following the sale, the insider now owns 25813.0 shares.
Still, SEC filings show that on Nov 11 ’24, WAGNER CHARLES F JR (EVP & Chief Financial Officer) disposed off 3,000 shares at an average price of $518.27 for $1.55 million. The insider now directly holds 44,137 shares of Vertex Pharmaceuticals, Inc (VRTX).
